PROGYNY, INC. (PGNY): Price and Financial Metrics

PROGYNY, INC. (PGNY): $36.52

1.87 (+5.40%)

POWR Rating

Component Grades








Add PGNY to Watchlist
Sign Up

Industry: Medical - Services




#49 of 67

in industry

PGNY Price/Volume Stats

Current price $36.52 52-week high $44.95
Prev. close $34.65 52-week low $29.44
Day low $35.02 Volume 2,095,900
Day high $37.20 Avg. volume 786,049
50-day MA $38.37 Dividend yield N/A
200-day MA $36.71 Market Cap 3.50B

PGNY Stock Price Chart Interactive Chart >


  • PGNY scores best on the Growth dimension, with a Growth rank ahead of 94% of US stocks.
  • The strongest trend for PGNY is in Growth, which has been heading up over the past 26 weeks.
  • PGNY ranks lowest in Value; there it ranks in the 23rd percentile.

PGNY Stock Summary

  • With a year-over-year growth in debt of 163.39%, PROGYNY INC's debt growth rate surpasses 94.61% of about US stocks.
  • Over the past twelve months, PGNY has reported earnings growth of 183.4%, putting it ahead of 93.64% of US stocks in our set.
  • Revenue growth over the past 12 months for PROGYNY INC comes in at 47.54%, a number that bests 90.62% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to PROGYNY INC, a group of peers worth examining would be EXPO, JEWL, CKX, IDCC, and CHCI.
  • Visit PGNY's SEC page to see the company's official filings. To visit the company's web site, go to

PGNY Valuation Summary

  • In comparison to the median Healthcare stock, PGNY's price/earnings ratio is 135.33% higher, now standing at 68.6.
  • Over the past 51 months, PGNY's price/earnings ratio has gone up 551.1.

Below are key valuation metrics over time for PGNY.

Stock Date P/S P/B P/E EV/EBIT
PGNY 2023-12-29 3.4 6.9 68.6 61.7
PGNY 2023-12-28 3.5 7.0 69.6 62.7
PGNY 2023-12-27 3.5 7.0 69.6 62.7
PGNY 2023-12-26 3.5 7.1 69.9 63.0
PGNY 2023-12-22 3.6 7.1 70.7 63.8
PGNY 2023-12-21 3.5 7.0 69.7 62.8

PGNY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PGNY has a Quality Grade of B, ranking ahead of 85.19% of graded US stocks.
  • PGNY's asset turnover comes in at 1.694 -- ranking 4th of 81 Healthcare stocks.
  • 500 - Internal server error

The table below shows PGNY's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.694 0.222 0.251
2021-03-31 1.663 0.213 0.173
2020-12-31 1.695 0.203 0.146
2020-09-30 1.744 0.198 0.078
2020-06-30 1.873 0.194 -0.499

PGNY Price Target

For more insight on analysts targets of PGNY, see our PGNY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $65.50 Average Broker Recommendation 1.25 (Strong Buy)

PROGYNY, INC. (PGNY) Company Bio

Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.

PGNY Latest News Stream

Event/Time News Detail
Loading, please wait...

PGNY Latest Social Stream

Loading social stream, please wait...

View Full PGNY Social Stream

Latest PGNY News From Around the Web

Below are the latest news stories about PROGYNY INC that investors may wish to consider to help them evaluate PGNY as an investment opportunity.

Executive Chairman David Schlanger Sells 162,906 Shares of Progyny Inc (PGNY)

On December 22, 2023, Executive Chairman David Schlanger sold 162,906 shares of Progyny Inc (NASDAQ:PGNY), as reported in a recent SEC Filing.

Yahoo | December 24, 2023

24 Countries With Biggest Population Decline

This article will list countries where population is continuously decreasing and highlight the major reasons behind this population decline. You can skip our detailed overview of the world’s population patterns and read 10 Countries With Biggest Population Decline. Recent estimates from the United Nations predict that the global population will reach approximately 8.5 billion by 2030, expand […]

Yahoo | December 19, 2023

4 Unstoppable Multibaggers to Buy in 2024 and Hold for the Next Decade

Even after posting solid results so far in 2023, these four stocks still offer long-term multibagger potential.

Yahoo | December 19, 2023

Returns On Capital Are Showing Encouraging Signs At Progyny (NASDAQ:PGNY)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Yahoo | December 4, 2023

Does Progyny (PGNY) have a Long Runway for Growth?

Polen Capital, an investment management company, released its “Polen Global SMID Company Growth Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The fund returned -6.59% gross and -6.64% net of fees compared to -3.55% return for the MSCI ACWI SMID Capitalization Index. Negative security selection drove the underperformance of the […]

Yahoo | November 20, 2023

Read More 'PGNY' Stories Here

PGNY Price Returns

1-mo -4.12%
3-mo 5.58%
6-mo -2.27%
1-year 0.80%
3-year -16.92%
5-year N/A
YTD -1.78%
2023 19.36%
2022 -38.13%
2021 18.78%
2020 54.43%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!